Cordarone
Cordarone Price range: $ 40,00 through $ 720,00
Back to products
Coumadin
Coumadin Price range: $ 12,00 through $ 153,00

Coreg

Price range: $ 41,00 through $ 651,00

Coreg is a highly effective beta-blocker medication used to manage various cardiovascular conditions. It is commonly utilized to treat hypertension, helping to lower high blood pressure and reduce the risk of strokes or heart attacks. This medication is also a primary choice for managing mild-to-severe heart failure by improving the heart’s pumping efficiency. Additionally, Coreg is used to increase survival rates in patients who have recently experienced a heart attack and have left ventricular dysfunction. By relaxing blood vessels and slowing the heart rate, Coreg helps the cardiovascular system function more effectively and improves overall patient outcomes.

Active substance: Carvedilol
SKU: Coreg Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Coreg belongs to a class of cardiovascular medications known as non-selective beta-adrenergic blockers with selective alpha-1 adrenergic blocking activity. It is a prescription-only drug approved by the US Food and Drug Administration (FDA) for managing conditions such as heart failure, left ventricular dysfunction following myocardial infarction, and hypertension.

Treatment with this agent requires individual dosage adjustment by a healthcare provider and continuous medical supervision. Taking this medication as prescribed helps lower blood pressure, improve heart pumping efficiency, and reduce cardiovascular mortality risks in appropriate clinical settings.

Basic Information

Parameter Details
Active ingredient (INN) Carvedilol
Therapeutic class Non-selective beta-blocker with alpha-1 blocking activity
Dosage form Oral tablet
Route of administration Oral
Prescription status Prescription only (Rx)
Primary purpose Management of heart failure, post-MI left ventricular dysfunction, hypertension

Main uses

Coreg is indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin. In clinical management, it is typically prescribed alongside standard therapies, including angiotensin-converting enzyme (ACE) inhibitors and diuretics, to decrease the risk of hospitalization and cardiovascular mortality. Additionally, it is FDA-approved for left ventricular dysfunction following a myocardial infarction in clinically stable patients, helping to improve post-heart-attack survival rates.

Another primary indication is the management of essential hypertension. Coreg may be used alone or in combination with other antihypertensive agents, such as thiazide diuretics. Unlabeled or off-label applications–such as rate control in atrial fibrillation or the prevention of variceal bleeding in patients with liver cirrhosis–are not primary FDA-approved indications for Coreg and must be evaluated strictly by a prescribing physician based on individual clinical risk factors.

How the drug works

Coreg exerts its therapeutic action through dual adrenergic receptor blockade. It competitively inhibits beta-1 and beta-2 adrenergic receptors while selectively blocking vascular alpha-1 adrenergic receptors. The alpha-1 blockade promotes peripheral vasodilation, which reduces systemic vascular resistance and lowers arterial blood pressure without inducing reflex tachycardia.

Concurrently, the beta-receptor blockade decreases heart rate, reduces cardiac workload, and lowers myocardial oxygen demand. Unlike conventional, non-vasodilating beta-blockers, carvedilol helps maintain renal blood flow and cardiac output while systemic resistance decreases. It also suppresses plasma renin activity and exhibits intrinsic antioxidant properties at high concentrations, providing comprehensive hemodynamic support for impaired cardiac tissue.

Dosing schedule

Coreg tablets are administered orally and must always be taken with food. Administering the medication with food slows the rate of gastrointestinal absorption, which minimizes the risk of orthostatic hypotension (a sudden drop in blood pressure upon standing up). Dosing schedules vary based on the specific condition being treated and must be carefully titrated under medical supervision.

For chronic heart failure, therapy typically initiates at a low dosage, such as 3.125 mg twice daily for two weeks. If tolerated, the dose is gradually doubled at two-week intervals to the highest tolerated level. For hypertension, the starting dose is usually 6.25 mg twice daily. Doses should not be altered, missed, or discontinued abruptly, as rapid withdrawal of beta-blockers can cause severe rebound hypertension, angina exacerbation, or myocardial infarction.

How it’s absorbed and eliminated

Following oral administration, Coreg is rapidly absorbed from the gastrointestinal tract. Absolute bioavailability is approximately 25% to 35% due to significant hepatic first-pass metabolism. Peak plasma concentrations are typically achieved within 1 to 2 hours after administration on an empty stomach, though taking the drug with food delays the time to reach peak concentration without altering overall systemic availability.

Carvedilol is highly plasma protein-bound (greater than 98%), primarily to albumin. It undergoes extensive hepatic metabolism via cytochrome P450 enzymes, primarily CYP2D6 and CYP2C9. The terminal elimination half-life ranges from 7 to 10 hours. Excretion occurs predominantly via the biliary system into the feces, with less than 2% of unchanged drug cleared through the kidneys.

What to avoid while taking it

Patients prescribed Coreg should avoid consuming alcohol, as ethanol can enhance the blood-pressure-lowering effect of carvedilol, increasing the risk of dizziness, syncope, or severe lightheadedness. Because the drug can cause orthostatic hypotension, patients should avoid rising quickly from sitting or lying positions.

Dietary interactions also warrant attention. Patients should consult their healthcare provider before using potassium supplements or salt substitutes containing potassium, as blood pressure medications can impact serum electrolyte levels. Additionally, patients should not alter their daily sodium intake drastically without medical guidance.

Compatibility with other medicines

Coreg exhibits significant interactions with several drug classes. Co-administration with strong CYP2D6 inhibitors (such as fluoxetine, paroxetine, or quinidine) can increase plasma concentrations of carvedilol. Concomitant use with digoxin can elevate serum digoxin concentrations by approximately 15%, requiring routine therapeutic drug monitoring.

Combining Coreg with calcium channel blockers that affect heart rhythm, such as diltiazem or verapamil, increases the risk of conduction disturbances and severe bradycardia (abnormally slow heart rate). Furthermore, carvedilol may potentiate the blood-sugar-lowering effect of insulin and oral antidiabetic drugs, while simultaneously masking early warning symptoms of hypoglycemia, particularly tachycardia.

Adverse reactions

Adverse reactions associated with Coreg are primarily related to its pharmacological action on the cardiovascular and nervous systems. In clinical trials, common side effects reported by patients include:

  • Dizziness and lightheadedness
  • Fatigue and general asthenia
  • Bradycardia (slow heart rate)
  • Hypotension (low blood pressure)
  • Diarrhea and nausea
  • Weight gain and peripheral edema (swelling of legs or ankles)

Less common adverse reactions include dry eyes, blurred vision, dyspnea (shortness of breath), extremity coldness, and erectile dysfunction. Hyperglycemia may occur, particularly in patients with pre-existing diabetes mellitus. Transient worsening of heart failure symptoms can also occur during the initial dosage titration phase.

Important precautions

Coreg carries major warnings regarding abrupt treatment cessation. Discontinuing therapy suddenly can precipitate acute exacerbation of angina, ventricular arrhythmias, or myocardial infarction. If discontinuation is necessary, the dosage must be gradually reduced over 1 to 2 weeks under close physician observation.

This medication is contraindicated in patients with bronchial asthma or severe chronic obstructive pulmonary disease (COPD) due to potential bronchospasm. It is also contraindicated in patients with second- or third-degree AV block (without a pacemaker), severe bradycardia, sick sinus syndrome, cardiogenic shock, or severe hepatic impairment. In elderly individuals, lower starting doses are recommended due to altered hepatic drug clearance. Safety and effectiveness in pediatric patients have not been established. During pregnancy, Coreg should be used only if the potential benefit justifies the potential risk to the fetus, and breastfeeding is not recommended during therapy.

If you skip a dose

If a dose of Coreg is missed, it should be taken as soon as remembered, provided it is taken with food. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely, and the regular dosing schedule should be resumed.

Never take two doses at the same time or take extra medicine to make up for a missed dose. Taking an excessive amount of carvedilol significantly increases the risk of severe bradycardia, profound hypotension, and loss of consciousness.

Storage and expiration

Store Coreg tablets at controlled room temperature between 68°F and 77°F (20°C to 25°C). Brief excursions are permitted between 59°F and 86°F (15°C and 30°C) in accordance with standard pharmaceutical guidelines. Keep the container tightly closed to protect the medication from moisture and light.

Do not store tablets in humid environments, such as bathroom cabinets. Expired or unused medication should not be flushed down the toilet. Safely dispose of unused tablets through community pharmacy take-back programs or municipal waste disposal facilities (such as those operating in Houston or other US municipalities). Keep all medications out of the reach of children and pets.

When to get emergency care

Certain adverse reactions require immediate medical evaluation. Patients and caregivers should recognize key red-flag symptoms that indicate a potential drug overdose or severe adverse reaction.

Red Flag Symptom Potential Clinical Significance
Swelling of face, lips, tongue, or throat Severe allergic reaction or angioedema
Severe difficulty breathing or wheezing Bronchospasm or acute heart failure exacerbation
Extreme bradycardia (heart rate under 50 bpm) Severe heart block or sinus node dysfunction
Chest pain, pressure, or irregular heartbeats Ischemic cardiac event or serious arrhythmia
Fainting, severe dizziness, or loss of consciousness Profound hypotension or decreased cardiac output
Sudden, unexplained rapid weight gain with severe swelling Acute fluid retention and decompensated heart failure

Common questions

Can Coreg mask the symptoms of low blood sugar in diabetic patients?

Yes. Coreg is a beta-blocker, and this class of medication can mask classic physiological warning signs of hypoglycemia, such as a rapid heart rate (tachycardia) and tremors. However, dizziness and sweating are typically not masked. Diabetic patients monitoring their blood glucose levels should be particularly vigilant during treatment initiation or dose adjustments.

Why is it necessary to take Coreg with food?

Taking Coreg with food slows down its rate of absorption in the gastrointestinal tract. This slower absorption rate helps prevent rapid drops in blood pressure, reducing the risk of orthostatic dizziness and lightheadedness upon standing. It does not reduce the overall amount of medication absorbed by the body.

What should I do if my heart rate drops significantly below 55 beats per minute?

If your resting heart rate consistently drops below 55 beats per minute, or if low heart rate is accompanied by dizziness, fatigue, or confusion, contact your healthcare provider. Your prescriber may need to evaluate your heart rhythm and consider reducing your daily dosage.

Can Coreg cause cold hands and feet?

Yes. Reduced peripheral circulation is a recognized effect of beta-adrenergic blockade. By decreasing cardiac output and blocking vascular receptors, Coreg can reduce blood flow to the extremities, leading to cold hands or feet. Patients should inform their doctor if this symptom becomes severe or painful.

Is it safe to stop taking Coreg suddenly if I feel completely healthy?

No. You should never stop taking Coreg abruptly. Suddenly stopping beta-blockers can lead to a dangerous spike in blood pressure, severe chest pain, or a heart attack, even in patients who feel fine. Any reduction in dose or discontinuation must be executed gradually under direct medical supervision.

Information on this page is for reference and does not replace an assessment by a licensed healthcare professional. In accordance with FDA requirements.

Additional information
Dosage

3.125 mg

,

6.25 mg

,

12.5 mg

,

25mg

Package

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία